{
  "docId": "019de518-8e47-70ef-8cf8-4bcd672f9030",
  "docSlug": "d07a146faad03c0afc104a3db080e8ce",
  "documentTitle": "Avantor | Results Presentation Deck | 18 slides",
  "authorId": "avantor",
  "authorName": "Avantor",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 13,
  "pageCount": 18,
  "prevPage": 12,
  "nextPage": 14,
  "slideType": "kpi_overview",
  "function": "analyze_data",
  "density": "dense",
  "nDataPoints": 252,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de518-8e47-70ef-8cf8-4bcd672f9030/13",
  "deckHref": "/decks/019de518-8e47-70ef-8cf8-4bcd672f9030",
  "deckJsonHref": "/decks/019de518-8e47-70ef-8cf8-4bcd672f9030.json",
  "deckAnchorHref": "/decks/019de518-8e47-70ef-8cf8-4bcd672f9030#slide-13",
  "components": [
    {
      "bbox": {
        "h": 0.03,
        "w": 0.704,
        "x": 0.199,
        "y": 0.94
      },
      "kind": "source-note",
      "text": "Note: Total Avantor includes impact of corporate-level adjusted operating expenses. Corporate segment does not report revenues.\n1. Please refer to schedule #4 for a reconciliation of GAAP net income to consolidated Adjusted Operating Income.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "66bb90f2-99a4-41a9-a5c1-da46a820af46",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.013,
        "w": 0.099,
        "x": 0.081,
        "y": 0.103
      },
      "kind": "subtitle",
      "text": "USD in millions",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "231b8586-b427-4cfa-8b24-6fb57111b77a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.76,
        "w": 0.63,
        "x": 0.199,
        "y": 0.15
      },
      "kind": "table",
      "text": "Lab Solutions segment (\"LSS\") Consolidated net sales (GAAP) (unaudited) 1Q23 $1,203 (unaudited) 2Q23 $1,194 (unaudited) 3Q23 $1,159 (unaudited) 4Q23 $1,182 (unaudited) 1Q24 $1,157 (unaudited) 2Q24 $1,156 (unaudited) 3Q24 $1,172 Core organic growth (decline) -$46 -3.5% -$44 -3.5% -$60 -4.9% -$19 -1.6% -$55 -4.5% -$33 -2.7% $7 0.6% COVID impact -43 -3.2% -33 -2.6% -33 -2.7% -17 -1.4% -9 0.7% -5 -0.5% 5 0.5% Organic growth (decline) -$89 -6.7% -$77 -6.1% -$94 -7.7% -$36 -3.0% -$55 -4.5% -$38 -3.2% $12 1.1% FX impact -33 -2.5% 6 0.5% 33 2.7% 26 2.2% 9 0.7% -5 -0.5% 5 0.5% Reported net sales growth (decline) -$122 -9.2% -$71 -5.6% -$61 -5.0% -$10 -0.9% -$46 -3.8% -$38 -3.2% $12 1.1% Adjusted Operating Income (non-GAAP)¹ $172 $180 $159 $157 $148 $151 $152 Adjusted Operating Income margin 14.3% 15.1% 13.7% 13.3% 12.8% 13.1% 12.9% Adjusted Operating Income margin growth (-bps) -290 bps 20 bps -100 bps -90 bps -150 bps -200 bps -80 bps Bioscience Production segment (\"BPS\") Consolidated net sales (GAAP) (unaudited) 1Q23 $577 (unaudited) 2Q23 $550 (unaudited) 3Q23 $561 (unaudited) 4Q23 $540 (unaudited) 1Q24 $523 (unaudited) 2Q24 $547 (unaudited) 3Q24 $543 Core organic growth (decline) $11 1.8% -$80 -12.4% -$86 -13.6% -$69 -11.4% -$58 -10.0% -$2 -0.3% -$20 -3.5% COVID impact -51 -8.1% -18 -2.7% 2 0.2% -1 -0.2% 3 0.5% -1 -0.2% 2 0.3% Organic growth (decline) -$39 -6.3% -$97 -15.1% -$85 -13.3% -$70 -11.6% -$55 -9.5% -$3 -0.5% -$18 -3.2% FX impact -9 -1.4% 1 0.2% 10 1.5% 8 1.3% 3 0.5% -1 -0.2% 2 0.3% Reported net sales growth (decline) -$48 -7.7% -$96 -14.9% -$75 -11.8% -$62 -10.3% -$55 -9.5% -$3 -0.5% -$18 -3.2% Adjusted Operating Income (non-GAAP)¹ $168 $154 $148 $132 $127 $144 $138 Adjusted Operating Income margin 29.0% 28.0% 26.4% 24.4% 24.3% 26.3% 25.4% Adjusted Operating Income margin growth (-bps) -80 bps -470 bps -510 bps -560 bps -470 bps -170 bps -100 bps Corporate segment Adjusted Operating Income (non-GAAP)¹ (unaudited) 1Q23 -$17 (unaudited) 2Q23 -$15 (unaudited) 3Q23 -$12 (unaudited) 4Q23 -$14 (unaudited) 1Q24 -$17 (unaudited) 2Q24 -$18 (unaudited) 3Q24 -$15 Consolidated net sales (GAAP) (unaudited) 1Q23 $ (unaudited) 2Q23 $ (unaudited) 3Q23 $ (unaudited) 4Q23 $ (unaudited) 1Q24 $ (unaudited) 2Q24 $ (unaudited) 3Q24 $ Lab Solutions segment (\"LSS\") 1,203 1,194 1,159 1,182 1,157 1,156 1,172 Bioscience Production segment (\"BPS\") 577 550 561 540 523 547 543 Corporate segment Total Avantor $1,780 $1,744 $1,720 $1,723 $1,680 $1,703 $1,714 Adjusted Operating Income (non-GAAP)¹ Lab Solutions segment (\"LSS\") 172 180 159 157 148 151 152 Bioscience Production (\"BPS\") 168 154 148 132 127 144 138 Corporate segment -17 -15 -12 -14 -17 -18 -15 Total Avantor $323 $319 $295 $275 $258 $277 $275 Adjusted Operating Income margin 18.1% 18.3% 17.1% 16.0% 15.4% 16.3% 16.0% Adjusted Operating Income margin growth (-bps) -230 bps -160 bps -230 bps -270 bps -270 bps -200 bps -110 bps",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ae25b12b-72a5-457f-a0d2-8c7e43e7e64b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.67,
        "x": 0.081,
        "y": 0.07
      },
      "kind": "title",
      "text": "Segment Growth & Profitability Measures (Quarterly)",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6368e4f8-8441-4ee9-86f3-fda230ea99a1",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Table data",
      "slug": "table-data",
      "agent": null,
      "layer": "slide",
      "matchId": "636f5e2a-7ee6-4073-ab6d-b1184be33e30",
      "evidence": "components contain a table with data",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 15,
      "from": 6,
      "beatId": "dd2d7508-9ef1-46e1-b693-a1d5151f7d92",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "Revenue Buildup",
      "beatSlug": null,
      "evidence": "Adjusted EPS and Consolidated Adjusted P&L",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    },
    {
      "to": 17,
      "from": 4,
      "beatId": "58229d7b-290b-4ee8-93c0-85eeab88e890",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "Evidence",
      "beatSlug": "evidence",
      "evidence": "Detailed financial metrics and KPIs",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [
    {
      "to": 15,
      "from": 10,
      "name": "Zoom In",
      "slug": "06-zoom-in",
      "bestFor": "Technical deep-dives, case studies, detailed analysis",
      "matchId": "0bbc76a3-0222-4597-933b-e4cc7d0efad1",
      "evidence": "Adjusted EPS and Consolidated Adjusted P&L",
      "position": 1,
      "objective": "Zoom in on adjusted EPS and P&L",
      "structure": "The Big Picture -> Key Area of Focus -> Specific Detail -> Implication",
      "confidence": 0.6,
      "description": "Start broad, then progressively focus on specific details that prove your point"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}